Search Results - "Malainou, Christina"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Alveolar macrophages in tissue homeostasis, inflammation, and infection: evolving concepts of therapeutic targeting by Malainou, Christina, Abdin, Shifaa M, Lachmann, Nico, Matt, Ulrich, Herold, Susanne

    Published in The Journal of clinical investigation (01-10-2023)
    “…Alveolar macrophages (AMs) are the sentinel cells of the alveolar space, maintaining homeostasis, fending off pathogens, and controlling lung inflammation…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Influenza virus decreases albumin uptake and megalin expression in alveolar epithelial cells by Alberro-Brage, Andrés, Kryvenko, Vitalii, Malainou, Christina, Günther, Stefan, Morty, Rory E., Seeger, Werner, Herold, Susanne, Samakovlis, Christos, Vadász, István

    Published in Frontiers in immunology (01-09-2023)
    “…IntroductionAcute respiratory distress syndrome (ARDS) is a common complication of influenza virus (IV) infection. During ARDS, alveolar protein concentrations…”
    Get full text
    Journal Article
  4. 4

    Estrogen-Receptor-Low-Positive Breast Cancer: Pathological and Clinical Perspectives by Malainou, Christina Panagiotis, Stachika, Nikolina, Damianou, Aikaterini Konstantina, Anastopoulos, Aristotelis, Ploumaki, Ioanna, Triantafyllou, Efthymios, Drougkas, Konstantinos, Gomatou, Georgia, Kotteas, Elias

    Published in Current oncology (Toronto) (01-11-2023)
    “…The expression of estrogen receptors (ERs) in breast cancer (BC) represents a strong prognostic and predictive biomarker and directs therapeutic decisions in…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Progress and Challenges of Messenger RNA Vaccines in the Therapeutics of NSCLC by Kiousi, Eftychia, Lyraraki, Vasiliki, Mardiki, Georgia Lamprini, Stachika, Nikolina, Damianou, Aikaterini Konstantina, Malainou, Christina Panagiotis, Syrigos, Nikolaos, Gomatou, Georgia, Kotteas, Elias

    Published in Cancers (26-11-2023)
    “…The introduction of immune checkpoint inhibitors in the therapeutics of non-small cell lung cancer (NSCLC) has been a game-changer in the management of…”
    Get full text
    Journal Article